This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Agency for Science, Technology and Research. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2024
Title: Innovations of Pingyu Zhong in Monoclonal Antibodies
Introduction
Pingyu Zhong is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of five patents to his name, Zhong's work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Zhong's latest patents include the development of IL-1β neutralizing human monoclonal antibodies. This invention is directed to antigen binding proteins, specifically targeting IL-1β antigen binding proteins. The patent further provides compositions comprising these antigen binding proteins, their uses, and methods for production. This innovative work showcases Zhong's commitment to advancing medical science through targeted therapies.
Career Highlights
Zhong is affiliated with the Agency for Science, Technology and Research, where he continues to push the boundaries of scientific research. His career is marked by a dedication to developing solutions that address critical health challenges.
Collaborations
Zhong has collaborated with esteemed colleagues, including Cheng-I Wang and Angeline Goh. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in achieving groundbreaking innovations.
Conclusion
Pingyu Zhong's contributions to the field of monoclonal antibodies exemplify the impact of innovative research in biotechnology. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
